VIM and colonic neoplasm: DCLK1 contributes to the promotion of EMT by means of the overexpression of mesenchymal markers (Vimentin) and transcriptional regulators (ZEB1) and the downregulation of the epithelial marker E-cadherin in colon cancer cells [14, 17, 35].